Andexanet alfa, sold under the brand name Andexxa among others, is an antidote for the medications rivaroxaban and apixaban, when reversal of anticoagulation... 14 KB (1,177 words) - 04:30, 31 March 2024 |
 | reuptake inhibitors, and nonsteroidal anti-inflammatory drugs (NSAIDs). Andexanet alfa is a US Food and Drug Administration (FDA) approved antidote for apixaban... 23 KB (1,889 words) - 02:56, 7 March 2024 |
 | DOACs are not as widely studied, idarucizumab (for dabigatran) and andexanet alfa (for factor Xa inhibitor) have been used in clinical settings with varying... 78 KB (8,726 words) - 15:18, 29 April 2024 |
asfotase alfa (Strensiq), used to treat hypophosphatasia; sebelipase alfa (Kanuma), used to treat lysosomal acid lipase deficiency, and andexanet alfa (Andexxa)... 20 KB (1,377 words) - 17:48, 12 March 2024 |
 | v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide... 21 KB (2,196 words) - 21:28, 13 April 2024 |
 | trials for andexanet alfa as an antidote for Factor Xa inhibitors with few adverse effects, and started Phase III trials. Andexanet alfa was approved... 28 KB (2,481 words) - 12:40, 12 May 2024 |
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide... 10 KB (723 words) - 23:45, 8 May 2024 |
 | v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide... 31 KB (2,754 words) - 05:58, 1 April 2024 |
 | v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide... 18 KB (1,668 words) - 03:20, 20 April 2024 |
 | dabigatran (idarucizumab), and for apixaban, and rivaroxaban (andexanet alfa). Andexanet alfa is suggested for edoxaban, but use of it is considered off... 94 KB (9,772 words) - 05:31, 19 April 2024 |